Vaginal Microbiome Program
Vaginal dysbiosis and health
Key Facts
About Viramal
Viramal is a private, clinical-stage biotech company pioneering women's health therapeutics through its proprietary Fem Med Tech™ platform. Founded in 2013 (incorporated 2017), the company is developing a pipeline of prescription and non-prescription products for conditions like endometriosis, menopause, and chronic pelvic pain, emphasizing targeted, non-invasive delivery to avoid systemic side effects. Led by a team with deep experience in women's health and biotech, Viramal operates from London and Sweden, targeting a large, underserved market with therapies designed to be more tolerable and effective than current standards. The company is currently pre-revenue, advancing its portfolio through clinical development.
View full company profile